The multiple uses of fluorescent proteins to visualize cancer in vivo

RM Hoffman - Nature Reviews Cancer, 2005 - nature.com
Naturally fluorescent proteins have revolutionized biology by enabling what was formerly
invisible to be seen clearly. These proteins have allowed us to visualize, in real time …

Advantages of patient‐derived orthotopic mouse models and genetic reporters for developing fluorescence‐guided surgery

TM Lwin, RM Hoffman, M Bouvet - Journal of surgical oncology, 2018 - Wiley Online Library
Fluorescence‐guided surgery can enhance the surgeon's ability to achieve a complete
oncologic resection. There are a number of tumor‐specific probes being developed with …

[HTML][HTML] Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft (PDOX) …

T Murakami, J DeLong, FC Eilber, M Zhao, Y Zhang… - Oncotarget, 2016 - ncbi.nlm.nih.gov
A patient with high grade undifferentiated pleomorphic soft-tissue sarcoma from a striated
muscle was grown orthotopically in the right biceps femoris muscle of mice to establish a …

[HTML][HTML] Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model

M Yamamoto, M Zhao, Y Hiroshima, Y Zhang… - PLoS …, 2016 - journals.plos.org
Tumor-targeting Salmonella enterica serovar Typhimurium A1-R (Salmonella A1-R) had
strong efficacy on a melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse …

[HTML][HTML] Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma patient-derived …

T Murakami, AS Singh, T Kiyuna, SM Dry, Y Li… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Ewing's sarcoma is a rare and aggressive malignancy. In the present study, tumor from a
patient with a Ewing's sarcoma with cyclin-dependent kinase inhibitor 2A/B (CDKN2A/B) …

Oral recombinant methioninase (o-rMETase) is superior to injectable rMETase and overcomes acquired gemcitabine resistance in pancreatic cancer

K Kawaguchi, K Miyake, Q Han, S Li, Y Tan, K Igarashi… - Cancer Letters, 2018 - Elsevier
Recombinant methioninase (rMETase) was previously administered as an injectable drug to
target methionine dependence of cancer. Recently, we observed that rMETase could be …

[HTML][HTML] Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma in a patient-derived orthotopic xenograft …

K Kawaguchi, K Igarashi, S Li, Q Han, Y Tan, T Kiyuna… - Oncotarget, 2017 - ncbi.nlm.nih.gov
An excessive requirement for methionine termed methionine dependence, appears to be a
general metabolic defect in cancer. We have previously shown that cancer-cell growth can …

[HTML][HTML] Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600E mutation in a patient …

K Kawaguchi, K Igarashi, T Murakami, B Chmielowski… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Melanoma is a recalcitrant disease in need of transformative therapuetics. The present study
used a patient-derived orthotopic xenograft (PDOX) nude-mouse model of melanoma with a …

Tumor-targeting Salmonella typhimurium A1-R combined with recombinant methioninase and cisplatinum eradicates an osteosarcoma cisplatinum-resistant lung …

K Igarashi, K Kawaguchi, T Kiyuna, K Miyake… - Cell Cycle, 2018 - Taylor & Francis
In the present study, a patient-derived orthotopic xenograft (PDOX) model of recurrent
cisplatinum (CDDP)-resistant metastatic osteosarcoma was treated with Salmonella …

[HTML][HTML] Vemurafenib-resistant BRAF-V600E-mutated melanoma is regressed by MEK-targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic …

K Kawaguchi, T Murakami, B Chmielowski, K Igarashi… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Melanoma is a recalcitrant disease. The present study used a patient-derived orthotopic
xenograft (PDOX) model of melanoma to test sensitivity to three molecularly-targeted drugs …